Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure

Servier

Status and phase: Completed; Phase 2

Conditions: Heart Failure, Congestive

Treatments: Drug: Ivabradine

Study type: Interventional

Funder types: Other

Identifiers

NCT00202579

CL2-16257-053

Details and patient eligibility

About

To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure

Enrollment: 12 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• systolic congestive heart failure
• sinus rhythm, HR >= 80bpm

Exclusion criteria

• unstable cardiovascular condition